The Ministry of Foreign and European Affairs wishes to inform that the Grand Duchy of Luxembourg has acted on Council Recommendation (EU) 2021/1085 of 1 July 2021 amending Recommendation (EU) 2020/912 on the temporary restriction on non-essential travel to the European Union and the possible lifting of this restriction .
The list of third countries whose population should not be affected by a temporary restriction on the external borders of non-essential trips to the Grand Duchy of Luxembourg is updated with the addition of Saudi Arabia, Armenia and Azerbaijan as of July 12, 2021., Bosnia and Herzegovina, Brunei Darussalam, Canada, Jordan, Kosovo, Republic of Moldova, Montenegro and Qatar.
Third-country nationals residing in Saudi Arabia, Armenia, Azerbaijan, Bosnia and Herzegovina, Brunei Darussalam, Canada, Jordan, Kosovo, Republic of Moldova, Montenegro and Qatar will again be allowed to enter the territory of the Grand Duchy of Luxembourg from July 12. , 2021.
Proof of residence is the responsibility of the third country citizen.
The updated list of the third countries whose residents are allowed to enter the territory of the Grand Duchy of Luxembourg looks like this:
- Saudi Arab
- Bosnia and Herzegovina
- Brunei Darussalam
- China (subject to confirmation of reciprocity at the EU level)
- South Korea
- United States of America
- The Zionist entity
- the black Mountain
- New Zealand
- North Macedonia
- Republic of Moldova
- Special Administrative Regions of the People’s Republic of China
- Hong Kong RA
- Macau Special Administrative Region
- Entities and regional authorities not recognized as states by at least one EU Member State
It is specified that the list relates only to the travel of third-country nationals to the Grand Duchy and not to the travel of Luxembourgians to the respective states, regions and entities.
As a reminder that anyone, from the age of 6, who wishes to travel by air transport to the Grand Duchy of Luxembourg must present when boarding:
- Either a vaccination certificate attesting to the complete vaccination schedule Produced with a vaccine that has received marketing authorization from the European Medicines Agency, the vaccines from the companies AstraZeneca, BioNTech/Pfizer, Johnson & Johnson and Moderna, established by a public or medical authority in an EU member state or member state of the Schengen area
- Either a certificate of recovery issued by a doctor or a national authority of an EU Member State or a Schengen Member State for people who have recently suffered from SARS-CoV-2 infection within 6 months prior to displacement and who have completed the isolation period applicable in the country concerned with no symptoms of infection
- Either a negative result (on paper or electronic document) of a nucleic acid amplification test (NAAT) for the detection of SARS-CoV-2 viral RNA (PCR, TMA, or LAMP methods)) less than 72 hours before flight or SARS-CoV-2 rapid antigen test performed less than 48 hours prior to the flight, by a medical laboratory or other body authorized for this purpose. The negative result of the intended test must be submitted, if necessary accompanied by a translation, in one of the administrative languages of Luxembourg or in English, Italian, Spanish or Portuguese.
Note that specific regulations for the UK and India are in effect until 15 July 2021.
The list of all exemptions provided as well as the exact terms of the actions to be carried out in advance can be consulted by following the link below: https://covid19.public.lu/fr/voyageurs/visiter-luxembourg.html.
 a) Any schedule specifying the number and intervals of injections necessary to obtain adequate protective immunity and which is completed when the necessary prescribed doses are given in the case of multiple doses or single-dose vaccinations, after a fourteen-day deficiency. b) For persons who have recovered and who have been vaccinated within 180 days of their first positive NAAT test result, the vaccination schedule is complete after a period of fourteen days after administration of the first dose. Regardless of the vaccine given.
 Meets WHO criteria: antigen detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays. Interim Guidance, September 11, 2020, and included in the list of rapid antigen tests established on the basis of Recommendation 2021/C24/01 of January 22, 2021.
Issued by the Ministry of Foreign and European Affairs